Clinical trial
Seroquel on Glucose Metabolism
NCT00214578 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00214578 |
|---|---|
| Title | Seroquel on Glucose Metabolism |
| Official title | Seroquel on Glucose Metabolism |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Seroquel (quetiapine) |
| Enrollment | 572 |
| Start date | Apr 1, 2004 |
| Completion | Oct 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 4, 2013 |
| Countries | Bulgaria, Czechia, Germany, Hungary, Norway, Romania, Slovakia, South Africa, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: